Effectiveness of Cinnamomum zeylanicum (Ceylon cinnamon) in lowering blood glucose in type 2 diabetes mellitus: a Randomized Double Blind Placebo Controlled Clinical Trial

niversity of Colombo0 个研究点开始时间: 待定最近更新: 2024年8月20日

适应症

试验速览

暂无简介。

•1. Male and female patients aged 18 – 70 years
•2. Diagnosed type 2 diabetes mellitus during the last 5 years
•3. Currently only on metformin or a sulphonyluria or both for the last 3 months
•4. HbA1c 6.5-8.0%
•5. Fasting blood glucose (FBG) 126-200 mg/dl

•1. Known allergy to cinnamon.
•2. Alcohol consumption >20g/day
•3. Diagnosed Alcoholic Liver Disease, cirrhosis or abnormal baseline liver function tests.
•4. Patients who are currently on hypoglycemic agents other than metformin or a sulphonyluria)
•5. Insulin therapy
•6. Raised baseline serum creatinine level (>1.5mg/dl in males or >1.2 mg/dl in females)
•7. Lactation, pregnancy or unwillingness to use an effective form of birth control for women of child bearing years.
•8. Symptoms suggestive of peptic ulcer disease
•9. Past history of peptic ulceration.
•10. Any diagnosed malignancy
•11. Cardiac, liver or respiratory failure
•12. Any other unrelated chronic illness
•13. Any condition in the opinion of the primary investigator that would contraindicate the patient's participation.

发起方

niversity of Colombo